NSRGY Stock Recent News

Seres Therapeutics said on Thursday it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of its bacterial infection drug and related intellectual property rights.

Nestle CEO Mark Schneider sat down exclusively with CNBC's Silvia Amaro, telling her the company saw pressure among consumers through the first quarter.

Nestle CEO Mark Schneider discusses the impact of GLP-1 drugs on the food industry and the company's products that are tailored to users of the drugs.

CNBC's Silvia Amaro sits down with Nestle CEO Mark Schneider for an exclusive conversation spanning food products, coffee and cocoa prices and the rise of GLP-1 drugs.

The rise of weight loss drugs means consumers' nutritional needs are "shifting," Nestle CEO Mark Schneider told CNBC's Silvia Amaro. Nestle is looking to capitalize on the popularity of the GLP-1 drugs with its "ambitious goal to push the healthier products," the CEO said.

Investors interested in Food - Miscellaneous stocks are likely familiar with Kerry Group PLC (KRYAY) and Nestle SA (NSRGY). But which of these two stocks offers value investors a better bang for their buck right now?

Imagine if, for every cup of coffee you bought, you instead invested that money into coffee stocks. I am not suggesting you stop drinking coffee.

The stock market is at record highs, but the next bear market could be right around the corner. Investors shouldn't become complacent and should be looking for the best defensive stocks to buy.

Nestle (OTCMKTS: NSRGY ) is getting into the weight loss business with new packs of frozen food designed for Ozempic users and others trying to slim down. Nestle is offering these frozen foods for weight loss through its new Vital Pursuit brand.

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Nestle's new frozen food brand, whether Americans should eat this food, and more.